晚期卵巢癌二次手术合并原发性免疫性血小板减少症一例并文献复习

doi:10.12280/gjfckx.20200717

国际妇产科学杂志 ›› 2021, Vol. 48 ›› Issue (3): 356-360.doi: 10.12280/gjfckx.20200717

• 妇科肿瘤研究病例报告 • 上一篇

晚期卵巢癌二次手术合并原发性免疫性血小板减少症一例并文献复习

刘媛, 陈思璐, 宋开蓉, 刘畅, 高丽, 杨永秀()

730000 兰州大学第一临床医学院（刘媛,陈思璐,宋开蓉）;兰州大学第一医院妇产科（刘畅,高丽,杨永秀）;甘肃省妇科肿瘤重点实验室（刘媛,陈思璐,宋开蓉,刘畅,高丽,杨永秀）

收稿日期:2020-08-03 出版日期:2021-06-15 发布日期:2021-06-25
通讯作者: 杨永秀 E-mail:yongxiuyang@163.com
基金资助:
兰州大学大学生创新创业行动计划项目;兰州大学第一临床医学院“卓越计划”学生科研创新培育项目(20190060150)

Secondary Surgery for Advanced Ovarian Cancer Combined with Primary Immune Thrombocytopenia: A Case Report and Literature Review

LIU Yuan, CHEN Si-lu, SONG Kai-rong, LIU Chang, GAO Li, YANG Yong-xiu()

The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China (LIU Yuan, CHEN Si-lu, SONG Kai-rong);Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Lanzhou 730000, China (LIU Chang, GAO Li, YANG Yong-xiu);Gansu Provincial Key Laboratory of Gynecological Oncology, Lanzhou 730000, China(LIU Yuan, CHEN Si-lu, SONG Kai-rong, LIU Chang, GAO Li, YANG Yong-xiu)

Received:2020-08-03 Published:2021-06-15 Online:2021-06-25
Contact: YANG Yong-xiu E-mail:yongxiuyang@163.com

摘要/Abstract

摘要：

原发性免疫性血小板减少症（primary immune thrombocytopenia,ITP）是一种获得性自身免疫性疾病,常与体内存在血小板抗体有关。ITP可继发于多种良恶性疾病,其中与实体肿瘤同时发生较为少见,而合并卵巢癌者更为少见。现报告1例晚期卵巢癌二次手术合并ITP的病例资料,并复习相关文献,以引起大家对本病的关注及认识,同时为以后的临床诊疗增加经验。

关键词: 原发性免疫性血小板减少症, 肿瘤化疗相关性血小板减少症, 卵巢肿瘤, 病例报告

Abstract:

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease. It is often associated with the presence of platelet antibodies in the body. ITP can be secondary to a variety of benign and malignant diseases, among which cooccurrence with solid tumors is rare, and cooccurrence with ovarian cancer is even rarer. This paper reports a case of advanced ovarian cancer complicated with ITP during the second operation, and reviews the relevant literature, in order to arouse people′s attention and understanding of this disease, and to add experience for the future clinical diagnosis and treatment.

Key words: Primary immune thrombocytopenia, Chemotherapy induced thrombocytopenia, Ovarian neoplasms, Case reports

刘媛, 陈思璐, 宋开蓉, 刘畅, 高丽, 杨永秀. 晚期卵巢癌二次手术合并原发性免疫性血小板减少症一例并文献复习[J]. 国际妇产科学杂志, 2021, 48(3): 356-360.

LIU Yuan, CHEN Si-lu, SONG Kai-rong, LIU Chang, GAO Li, YANG Yong-xiu. Secondary Surgery for Advanced Ovarian Cancer Combined with Primary Immune Thrombocytopenia: A Case Report and Literature Review[J]. Journal of International Obstetrics and Gynecology, 2021, 48(3): 356-360.

图/表 1

参考文献 17

[1]	Krauth MT, Puthenparambil J, Lechner K. Paraneoplastic autoimmune thrombocytopenia in solid tumors[J]. Crit Rev Oncol Hematol, 2012,81(1):75-81. doi: 10.1016/j.critrevonc.2011.02.004. doi: 10.1016/j.critrevonc.2011.02.004
[2]	Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood, 2011,117(16):4190-4207. doi: 10.1182/blood-2010-08-302984. doi: 10.1182/blood-2010-08-302984 pmid: 21325604
[3]	Liu XG, Bai XC, Chen FP, et al. Chinese guidelines for treatment of adult primary immune thrombocytopenia[J]. Int J Hematol, 2018,107(6):615-623. doi: 10.1007/s12185-018-2445-z. doi: 10.1007/s12185-018-2445-z
[4]	Audia S, Mahévas M, Samson M, et al. Pathogenesis of immune thrombocytopenia[J]. Autoimmun Rev, 2017,16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. doi: 10.1016/j.autrev.2017.04.012
[5]	MacDougall KN, Parylo S, Sokoloff A. A Case of Vancomycin-Induced Immune Thrombocytopenia[J]. Cureus, 2020,12(5):e7940. doi: 10.7759/cureus.7940. doi: 10.7759/cureus.7940
[6]	Bhattacharjee S, Banerjee M, et al. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review[J]. SN Compr Clin Med, 2020 Sep 19: 1-11. doi: 10.1007/s42399-020-00521-8. Epub ahead of print. doi: 10.1007/s42399-020-00521-8
[7]	Vayne C, Guéry EA, Rollin J, et al. Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia[J]. J Clin Med, 2020,9(7):2212. doi: 10.3390/jcm9072212. doi: 10.3390/jcm9072212
[8]	Machlus KR, Thon JN, Italiano JE Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation[J]. Br J Haematol, 2014,165(2):227-236. doi: 10.1111/bjh.12758. doi: 10.1111/bjh.12758
[9]	Stack A, Khanal R, Denlinger CS. Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review[J]. Clin Colorectal Cancer, 2021,20(1):e1-e4. doi: 10.1016/j.clcc.2020. 07.007. doi: 10.1016/j.clcc.2020. 07.007
[10]	Gangi A, Lu SC. Chemotherapy-associated liver injury in colorectal cancer[J]. Therap Adv Gastroenterol, 2020,13:1756284820924194. doi: 10.1177/1756284820924194. doi: 10.1177/1756284820924194
[11]	Weycker D, Hatfield M, Grossman A, et al. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice[J]. BMC Cancer, 2019,19(1):151. doi: 10.1186/s12885-019-5354-5. doi: 10.1186/s12885-019-5354-5 pmid: 30764783
[12]	Kim HD, Boggs DR. A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer[J]. Am J Med, 1979,67(3):371-377. doi: 10.1016/0002-9343(79)90781-2. doi: 10.1016/0002-9343(79)90781-2 pmid: 573065
[13]	Peffault de Latour R, Des Guetz G, Laurence V, et al. Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 cases[J]. Am J Clin Oncol, 2004,27(4):333-336. doi: 10.1097/01.coc.0000071461.61445.9a. doi: 10.1097/01.coc.0000071461.61445.9a
[14]	Kamesaki T. Autoimmune hemolytic anemia as a paraneoplastic syndrome associated with solid tumors[J]. Rinsho Ketsueki, 2015,56(7):778-784. doi: 10.11406/rinketsu.56.778. doi: 10.11406/rinketsu.56.778
[15]	Reitter S, Knoebl P, Pabinger I, et al. Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours[J]. Haemophilia, 2011,17(5):e889-894. doi: 10.1111/j.1365-2516. 2011.02522.x. doi: 10.1111/j.1365-2516. 2011.02522.x
[16]	Gómez-Puerta JA, Cervera R, Espinosa G, et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients[J]. Semin Arthritis Rheum, 2006,35(5):322-332. doi: 10.1016/j.semarthrit.2005.07.003. doi: 10.1016/j.semarthrit.2005.07.003
[17]	中国抗癌协会肿瘤临床化疗专业委员会, 中国抗癌协会肿瘤支持治疗专业委员会. 中国肿瘤化疗相关性血小板减少症专家诊疗共识(2019版)[J]. 中国医学前沿杂志(电子版), 2020,12(1):51-58. doi: 10.12037/YXQY.2020.01-07. doi: 10.12037/YXQY.2020.01-07

晚期卵巢癌二次手术合并原发性免疫性血小板减少症一例并文献复习

Secondary Surgery for Advanced Ovarian Cancer Combined with Primary Immune Thrombocytopenia: A Case Report and Literature Review

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 17

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈晓娟, 张艳馨. 妊娠合并血友病A患者足月分娩一例[J]. 国际妇产科学杂志, 2025, 52(2): 158-160.
[2]	赵鑫, 陈秀雯, 王雅楠, 王长智, 张夏兰. 妊娠合并重度凝血因子Ⅺ缺乏症二例[J]. 国际妇产科学杂志, 2025, 52(2): 161-164.
[3]	尹雨鑫, 王长河. 高龄女性盆腔深部侵袭性血管黏液瘤一例[J]. 国际妇产科学杂志, 2025, 52(2): 191-194.
[4]	王佳丽, 马国霞, 魏佳, 刘思敏, 杨永秀. 生殖系统T淋巴母细胞淋巴瘤一例[J]. 国际妇产科学杂志, 2025, 52(2): 195-199.
[5]	封玲, 李金林. 无乳链球菌感染致子宫穿孔并发感染性休克一例[J]. 国际妇产科学杂志, 2025, 52(2): 234-236.
[6]	白耀俊, 王思瑶, 令菲菲, 张森淮, 李红丽, 刘畅. Trop-2及靶向Trop-2抗体偶联药物在妇科恶性肿瘤中的应用进展[J]. 国际妇产科学杂志, 2025, 52(1): 1-7.
[7]	钟佩蕖, 招丽坚, 邹欣欣. 残角子宫妊娠行期待治疗至妊娠晚期一例[J]. 国际妇产科学杂志, 2025, 52(1): 114-116.
[8]	张云凤, 张宛玥, 卢悦, 王阳阳, 井佳雨, 牟婧祎, 王悦. ARID1A与PIK3CA突变在卵巢子宫内膜异位症恶变中的研究进展[J]. 国际妇产科学杂志, 2025, 52(1): 19-22.
[9]	李楠, 彭二玄, 刘风花. 卵巢上皮性癌脑转移20例临床分析[J]. 国际妇产科学杂志, 2025, 52(1): 23-27.
[10]	贾炎峰, 吴珍珍, 王维红, 王玥元, 李娟. 原发性卵巢腺鳞癌一例[J]. 国际妇产科学杂志, 2025, 52(1): 32-36.
[11]	宋丽芳, 吴珍珍, 毛宝宏, 赵小丽, 刘青. 卵巢癌腹股沟淋巴结孤立转移一例[J]. 国际妇产科学杂志, 2025, 52(1): 37-41.
[12]	张栋, 王筝, 李凯, 卞文丽, 高志华. 非妊娠期重度自发性卵巢过度刺激综合征一例[J]. 国际妇产科学杂志, 2025, 52(1): 79-83.
[13]	刘思敏, 李红丽, 郭希, 胡雅莉, 杨永秀. 妊娠晚期合并卵巢浆液性囊腺瘤蒂扭转一例[J]. 国际妇产科学杂志, 2024, 51(6): 632-635.
[14]	刘昱, 吴瑞芳, 李瑞珍. 宫颈癌ⅠB2期新辅助化疗根治性宫颈切除术后再妊娠一例[J]. 国际妇产科学杂志, 2024, 51(6): 669-671.
[15]	宋翰, 刘晗黎, 王希波. 宫颈癌背部软组织转移一例[J]. 国际妇产科学杂志, 2024, 51(6): 672-675.